Lack of in vitro synergy of clinically used antibodies specific for ICAM-1 and LFA-1

Author： Romer K. Herwartz C. Steinhoff G. Steinmann J.

Publisher： Elsevier

ISSN： 0966-3274

Source： Transplant Immunology, Vol.5, Iss.2, 1997-06, pp. : 162-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Manipulation of skin graft rejection in alloimmune mice by anti-VCAM-1:VLA-4 but not anti-ICAM-1:;LFA-1 monoclonal antibodies

By Gorczynski R.M. Chung S. Fu X.-M. Levy G. Sullivan B. Chen Z.

Transplant Immunology, Vol. 3, Iss. 1, 1995-03 ,pp. : 55-61

Elsevier

Access to resources Recommend Favorite

Time course of expression of ICAM-1 and LFA-1 in rat lung allografts

By Watanabe M. Takeichi N. Yasuda K.

Transplantation Proceedings, Vol. 31, Iss. 5, 1999-08 ,pp. : 2172-2174

Elsevier

Access to resources Recommend Favorite

Effect of ICAM-1/LFA-1 Blockade on Pancreatic Islet Allograft Survival, Function, and Early Cytokine Production

By Katz S.M. Tian L. Stepkowski S.M. Phan T. Bennett C.F. Kahan B.D.

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 748-749

Elsevier

Access to resources Recommend Favorite

LFA-1 and ICAM-1 antibody-idarubicin conjugates separately prolong murine cardiac allograft survival

By Pietersz G.A. Sandrin M.S. Ling S. Li Y.Q. McKenzie I.F.C.

Transplant Immunology, Vol. 9, Iss. 1, 2001-10 ,pp. : 7-11

Elsevier

Access to resources Recommend Favorite

Blocking ICAM-1 (CD54) and LFA-1 (CD11a) Inhibits Experimental Allergic Conjunctivitis

By Whitcup S.M. Chan C-C. Kozhich A.T. Magone M.T.

Clinical Immunology, Vol. 93, Iss. 2, 1999-11 ,pp. : 107-113

Academic Press

Access to resources Recommend Favorite